Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 40

1.

LITAF and TNFSF15, two downstream targets of AMPK, exert inhibitory effects on tumor growth.

Zhou J, Yang Z, Tsuji T, Gong J, Xie J, Chen C, Li W, Amar S, Luo Z.

Oncogene. 2011 Apr 21;30(16):1892-900. doi: 10.1038/onc.2010.575. Epub 2011 Jan 10.

2.

Commensal microbiota induce LPS hyporesponsiveness in colonic macrophages via the production of IL-10.

Ueda Y, Kayama H, Jeon SG, Kusu T, Isaka Y, Rakugi H, Yamamoto M, Takeda K.

Int Immunol. 2010 Dec;22(12):953-62. doi: 10.1093/intimm/dxq449. Epub 2010 Nov 3.

PMID:
21051439
3.

Identification and characterization of kava-derived compounds mediating TNF-alpha suppression.

Pollastri MP, Whitty A, Merrill JC, Tang X, Ashton TD, Amar S.

Chem Biol Drug Des. 2009 Aug;74(2):121-8. doi: 10.1111/j.1747-0285.2009.00838.x. Epub 2009 Jun 16.

4.

Treatment of inflammatory bowel disease: a review of medical therapy.

Kozuch PL, Hanauer SB.

World J Gastroenterol. 2008 Jan 21;14(3):354-77. Review.

5.

Therapeutic effect of epigallocatechin-3-gallate in a mouse model of colitis.

Abboud PA, Hake PW, Burroughs TJ, Odoms K, O'Connor M, Mangeshkar P, Wong HR, Zingarelli B.

Eur J Pharmacol. 2008 Jan 28;579(1-3):411-7. Epub 2007 Oct 30.

PMID:
18022615
6.

The inflammation-fibrosis link? A Jekyll and Hyde role for blood cells during wound repair.

Stramer BM, Mori R, Martin P.

J Invest Dermatol. 2007 May;127(5):1009-17. Review.

7.

LPS-induced TNF-alpha factor (LITAF)-deficient mice express reduced LPS-induced cytokine: Evidence for LITAF-dependent LPS signaling pathways.

Tang X, Metzger D, Leeman S, Amar S.

Proc Natl Acad Sci U S A. 2006 Sep 12;103(37):13777-82. Epub 2006 Sep 5. Erratum in: Proc Natl Acad Sci U S A. 2007 Feb 20;104(8):3015.

8.

Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis.

Sartor RB.

Nat Clin Pract Gastroenterol Hepatol. 2006 Jul;3(7):390-407. Review.

PMID:
16819502
9.

A new transcription factor that regulates TNF-alpha gene expression, LITAF, is increased in intestinal tissues from patients with CD and UC.

Stucchi A, Reed K, O'Brien M, Cerda S, Andrews C, Gower A, Bushell K, Amar S, Leeman S, Becker J.

Inflamm Bowel Dis. 2006 Jul;12(7):581-7.

PMID:
16804395
10.
11.

Tumor necrosis factor/tumor necrosis factor receptor family members that positively regulate immunity.

So T, Lee SW, Croft M.

Int J Hematol. 2006 Jan;83(1):1-11. Review.

PMID:
16443545
12.

NF-kappaB activation precedes increases in mRNA encoding neurokinin-1 receptor, proinflammatory cytokines, and adhesion molecules in dextran sulfate sodium-induced colitis in rats.

Reed KL, Fruin AB, Gower AC, Gonzales KD, Stucchi AF, Andry CD, O'Brien M, Becker JM.

Dig Dis Sci. 2005 Dec;50(12):2366-78.

PMID:
16416193
13.

Defects in mucosal immunity leading to Crohn's disease.

Cobrin GM, Abreu MT.

Immunol Rev. 2005 Aug;206:277-95. Review.

PMID:
16048555
14.

LPS induces the interaction of a transcription factor, LPS-induced TNF-alpha factor, and STAT6(B) with effects on multiple cytokines.

Tang X, Marciano DL, Leeman SE, Amar S.

Proc Natl Acad Sci U S A. 2005 Apr 5;102(14):5132-7. Epub 2005 Mar 25.

15.

New concepts in anti-tumor necrosis factor therapy for inflammatory bowel disease.

Sandborn WJ.

Rev Gastroenterol Disord. 2005 Winter;5(1):10-8. Review.

PMID:
15741928
16.
17.

Are there predictors of Remicade treatment success or failure?

Su C, Lichtenstein GR.

Adv Drug Deliv Rev. 2005 Jan 6;57(2):237-45. Review.

PMID:
15555740
18.

A neurokinin 1 receptor antagonist decreases postoperative peritoneal adhesion formation and increases peritoneal fibrinolytic activity.

Reed KL, Fruin AB, Gower AC, Stucchi AF, Leeman SE, Becker JM.

Proc Natl Acad Sci U S A. 2004 Jun 15;101(24):9115-20. Epub 2004 Jun 8.

19.
20.

The IKK NF-kappa B system: a treasure trove for drug development.

Karin M, Yamamoto Y, Wang QM.

Nat Rev Drug Discov. 2004 Jan;3(1):17-26. Review. No abstract available.

PMID:
14708018

Supplemental Content

Support Center